Breda Hennessey
Latest contributions
Procedural planning and risk stratification in multivessel PCI
22 May 2025 – From EuroPCR 2025
This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.
Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients
14 May 2024 – From EuroPCR 2024
Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE Neo2
09 Jun 2022
The ACURATE neo2 valve was developed to reduce the risk of paravalvular AR with an increased sealing skirt. This retrospective study aimed to compare TAVI with the ACURATE neo and neo2 devices.
Reviewer
Reviewer
Dealing with resistant vessels: new devices and techniques
19 May 2022 – From EuroPCR 2022
Discover new tools and methods to handle resistant vessels: bailout RotaTripsy technique, a novel case of orbital atherectomy and Intravascular lithotripsy for CTO bifurcation lesion.
FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG
12 Nov 2021
Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the FAME 3 trial presented at TCT 2021.
Coronary dissection - Part 1
28 Apr 2021 – From EuroPCR 2021
This session will help you know how to manage an iatrogenic intramural haematoma, how to treat a large pseudoaneurysm following PCI in SCAD, how to dissect flow-limiting spontaneous coronary, and much more!
